Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Solidifies Its Presence In China

This article was originally published in The Gray Sheet

Executive Summary

The association expects China's official recognition of its Shanghai office will make it easier to establish partnerships with Chinese authorities and will provide its members with more opportunities to engage on policy issues in the country.

You may also be interested in...



U.S., China Reach ‘Understanding’ To Eliminate Device Tariffs

After two years of back and forth, the two countries are close to a deal that would expand the World Trade Organization’s Information Technology Agreement and slash tariffs on high-tech products including medical devices.

AdvaMed Looks To Leverage U.S. Regs For Global Convergence

The trade group, under its new board chairman José Almeida, plans to push for the relatively new U.S. unique device identifier and Sunshine Act regulations to be the basis of globally harmonized mandates.

Celltrion Makes Progress On Coronavirus Treatment

Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.

Topics

UsernamePublicRestriction

Register

MT033076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel